<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
< Back to all Breaking News
GME, RIVN, MKC...
9/8/2022 12:09pm
What You Missed On Wall Street This Morning

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 


1. STOCK NEWS: 

  • McCormick (MKC) reported downbeat preliminary Q3 results and cut its FY22 earnings and revenue guidance [more]
  • GameStop (GME) reported better-than-expected Q2 earnings and announced a partnership with FTX [more]
  • Rivian (RIVN) and Mercedes-Benz (DDAIF) are seeking a joint venture for van manufacturing in Europe [more]
  • Regeneron (REGN) said that primary endpoints were met in its PHOTON and PULSAR trials as analysts called the results "game changing" and a "best case scenario" [more]
  • American Eagle (AEO) reported downbeat Q2 results [more]


2. WALL STREET CALLS: 

  • First Solar (FSLR) upgraded to Buy from Sell at Goldman Sachs [more]
  • Spirit AeroSystems (SPR) downgraded to Underweight from Overweight at Morgan Stanley [more]
  • Marqeta (MQ), FIS (FIS) and Cardlytics (CDLX) were all downgraded to Underweight at Wells Fargo [more]
  • Moderna (MRNA) upgraded to Buy with $165 target at Deutsche Bank [more]
  • MGM Resorts (MGM) downgraded to Hold from Buy at Argus [more]


3. AROUND THE WEB: 

  • JPMorgan (JPM) is considering buying a stake in fintech startup Yapily, Bloomberg reports [more]
  • ShockWave (SWAV) was called a "name to watch" by Dealreporter on M&A potential [more]
  • Amazon (AMZN) CEO Andy Jassy is not planning to force workers to return to the office, CNBC reports [more]
  • Spotify (SPOT) CEO Daniel Ek asked the European Commission to accelerate the company's case against Apple's (AAPL) practices, FT reports [more]
  • Bed Bath & Beyond's (BBBY) interim CEO was "concerned" about Arnal's wellbeing, WSJ reports [more]


4. MOVERS: 

  • Amylyx Pharmaceuticals (AMLX) gains after announcing the FDA AdCom voted in favor of approving AMX0035 in ALS [more]
  • Revance (RVNC) higher after the FDA approved its Daxxify injection [more]
  • Snap (SNAP) increases after the Verge said the company’s CEO projects $6B in 2023 revenue in a leaked memo [more]
  • Dave & Buster’s Entertainment (PLAY) declines after reporting quarterly results [more]
  • Sylvamo (SLVM) lower after announcing a 4.6M share offering priced at $36.25 [more]


5. EARNINGS/GUIDANCE: 

  • Asana (ASAN) reported upbeat Q2 results [more]
  • Bilibili (BILI) reported mixed Q2 results [more]
  • Byrna Technologies (BYRN) cut its FY22 revenue guidance [more]
  • MasterCraft Boat (MCFT) reported better-than-expected Q4 results [more]
  • Copart (CPRT) reported upbeat Q4 results [more]


INDEXES: 

Near midday, the Dow was down 131.33, or 0.42%, to 31,449.95, the Nasdaq was down 54.37, or 0.46%, to 11,737.53, and the S&P 500 was down 15.77, or 0.40%, to 3,964.10.

dynamic_feed Breaking News